About Remedium Bio
Remedium Bio is a company based in Needham (United States) founded in 2020 by Frank Luppino.. Remedium Bio has raised $3.5 million across 5 funding rounds from investors including MicroVentures, Guindy Alumni Angels and LifeSpan Vision Ventures. Remedium Bio offers products and services including Prometheus Platform, Gene Therapy for Obesity and T2D, and Gene Therapy for Stroke. Remedium Bio operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others.
- Headquarter Needham, United States
- Founders Frank Luppino
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.5 M (USD)
in 5 rounds
-
Latest Funding Round
-
Investors
MicroVentures
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Remedium Bio
Remedium Bio offers a comprehensive portfolio of products and services, including Prometheus Platform, Gene Therapy for Obesity and T2D, and Gene Therapy for Stroke. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Adjustable gene therapy for safe delivery of treatments
Single-injection therapy targeting weight loss and diabetes
Regenerative treatment for ischemic stroke recovery
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Remedium Bio
Remedium Bio has successfully raised a total of $3.5M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(16 Apr 2021)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Seed - Remedium Bio | Valuation | LifeSpan Vision Ventures |
|
| Aug, 2023 | Amount | Grant - Remedium Bio | Valuation |
investors |
|
| Aug, 2022 | Amount | Seed - Remedium Bio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Remedium Bio
Remedium Bio has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include MicroVentures, Guindy Alumni Angels and LifeSpan Vision Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Sherwood Ventures is engaged in management consulting with equity stakes.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Remedium Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Remedium Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Remedium Bio Comparisons
Competitors of Remedium Bio
Remedium Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Remedium Bio
Frequently Asked Questions about Remedium Bio
When was Remedium Bio founded?
Remedium Bio was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is Remedium Bio located?
Remedium Bio is headquartered in Needham, United States. It is registered at Needham, Massachusetts, United States.
Who is the current CEO of Remedium Bio?
Frank Luppino is the current CEO of Remedium Bio. They have also founded this company.
Is Remedium Bio a funded company?
Remedium Bio is a funded company, having raised a total of $3.5M across 5 funding rounds to date. The company's 1st funding round was a Seed of $2.3M, raised on Apr 16, 2021.
What does Remedium Bio do?
Remedium Bio was founded in 2020 and is based in Needham, United States. Gene therapies are developed for a range of diseases, particularly immune and age-related conditions. The pipeline encompasses RMD 1101 for rheumatology, RMD 1202 for endocrinology, RMD 1501 for neurology, and RMD 1201 for Type-1 diabetes. Operations are conducted in the biotechnology sector, with emphasis on therapeutic advancements for these areas.
Who are the top competitors of Remedium Bio?
Remedium Bio's top competitors include Moderna, Spark Therapeutics and BridgeBio.
What products or services does Remedium Bio offer?
Remedium Bio offers Prometheus Platform, Gene Therapy for Obesity and T2D, and Gene Therapy for Stroke.
Who are Remedium Bio's investors?
Remedium Bio has 9 investors. Key investors include MicroVentures, Guindy Alumni Angels, LifeSpan Vision Ventures, National Science Foundation, and Sherwood Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.